John Ahn is a Regulatory Affairs professional with extensive experience in the pharmaceutical industry. They managed critical regulatory submissions and lifecycle aspects at Gilead Sciences between 2015 and 2020 and have held senior managerial roles at Glaukos Corporation since 2020 and BioMarin Pharmaceutical Inc. since 2025. Ahn earned a Bachelor of Science in Chemistry from UC San Diego and a Master of Science in Regulatory Affairs from Northeastern University. Their expertise includes managing complex regulatory strategies for drug-device combination products and authoring key regulatory documents.
This person is not in the org chart
This person is not in any teams
This person is not in any offices